ClinicalTrials.Veeva

Menu

High Sensitive CRP in Prediabetics and Diabetes

F

Fayoum University

Status

Completed

Conditions

Assess Level of High Sensitive CRP in Diabetics and Prediabetics

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study was to study the level of high-sensitivity CRP in sera of pre-diabetic and newly diagnosed patients with type 2 diabetes mellitus and its correlation with HOMA IR and HbA1c

Full description

This study will include (180) subjects, 60 pre-diabetic patients, 60 patients with newly diagnosed type 2 diabetes ( within one month of diagnosis) and 60 normal healthy non diabetic individuals as a control group. The study individuals will be recruited from the Diabetes and Internal Medicine Clinics of Fayoum University Hospital

Enrollment

180 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pre-diabetic patients:

    • A fasting blood glucose level (100 to 125 mg/dL). or
    • A 2-hour blood glucose level (140 to 199 mg/dL) .or
    • Hb A1C 5.7% to 6.4%.
  • Newly diagnosed type 2 diabetes: (maximum within one month from diagnosis)

    • A fasting blood glucose level >126 mg/dl
    • A 2-hour blood glucose level > 200 mg/dl
    • Hb A1C > 6.5%

Exclusion criteria

  • Pregnant or lactating females.
  • Patients who have recent infection.
  • Patients with acute inflammatory diseases as autoimmune diseases.
  • Patients with malignancy or on chemotherapy.
  • Patients with acute or chronic liver or renal diseases

Trial design

180 participants in 2 patient groups

Prediabetics
Description:
Ages ranging from 18 to 60 years old,males and females were included . A fasting blood glucose level (100 to 125 mg/dL). or A 2-hour blood glucose level (140 to 199 mg/dL) .or Hb A1C 5.7% to 6.4%.
Newly diagnosed type 2 diabetes
Description:
Ages ranging from 18 to 60 years old,males and females were included Newly diagnosed type 2 diabetes: (maximum within one month from diagnosis) A fasting blood glucose level \>126 mg/dl A 2-hour blood glucose level \> 200 mg/d Hb A1C \> 6.5%

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems